ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Mammography and Breast Arterial Calcification: An Information-Sharing Trial

Not Applicable

Recruiting

Conditions: Vascular Calcification
Mammography

Interventions: Behavioral: BAC-Enhanced Letter
Behavioral: Waitlist Control

First Posted Date: 2021-07-30

Last Posted Date: 2023-10-05

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 14875

Registration Number: NCT04983875

Locations: 🇺🇸
Mount Sinai, New York, New York, United States

Targeting IL-17A for Treatment-Resistant Depression

Phase 2

Recruiting

Conditions: Major Depressive Disorder

Interventions: Drug: Ixekizumab

First Posted Date: 2021-07-28

Last Posted Date: 2024-08-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 20

Registration Number: NCT04979910

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Community Interest in Vision Screening Technology

Completed

Conditions: Ophthalmology
Vision Screening

Interventions: Device: Virtual Reality

First Posted Date: 2021-07-28

Last Posted Date: 2024-08-28

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 1000

Registration Number: NCT04980430

Locations: 🇺🇸
Mount Sinai Ophthalmology Faculty Practice Associates, New York, New York, United States

Truncal Blocks Versus Wound Infiltration for SICD

Not Applicable

Completed

Conditions: Postoperative Pain
Intraoperative Pain

Interventions: Procedure: Truncal blocks
Procedure: Wound infiltration

First Posted Date: 2021-07-23

Last Posted Date: 2022-08-04

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 24

Registration Number: NCT04974762

Locations: 🇺🇸
Mount Sinai Morningside Hospital Center, New York, New York, United States

Cognitive Reappraisal Training for Borderline Personality

Not Applicable

Completed

Conditions: Borderline Personality Disorder

Interventions: Behavioral: Control Downregulate Condition
Behavioral: Cognitive Reappraisal by Distancing

First Posted Date: 2021-07-19

Last Posted Date: 2024-07-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 60

Registration Number: NCT04967222

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Remote Gamified Sensory Perceptual Training for Patients With Fibromyalgia: a Feasibility Trial

Not Applicable

Completed

Conditions: Fibromyalgia

Interventions: Device: TrainPain

First Posted Date: 2021-06-09

Last Posted Date: 2022-06-16

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 11

Registration Number: NCT04919525

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Caregiver Support and Post-operative Convalescence

Completed

Conditions: Pelvic Organ Prolapse

First Posted Date: 2021-05-21

Last Posted Date: 2022-11-22

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 103

Registration Number: NCT04897061

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD

Phase 2

Completed

Conditions: PTSD

Interventions: Drug: Ketamine
Behavioral: Written Exposure Therapy

First Posted Date: 2021-05-17

Last Posted Date: 2024-10-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 16

Registration Number: NCT04889664

Locations: 🇺🇸
Depression and Anxiety Center, Icahn School of Medicine at Mount Sinai, Manhattan, New York, United States

Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus

Not Applicable

Completed

Conditions: Gestational Diabetes

Interventions: Other: Glucose Monitoring

First Posted Date: 2021-04-23

Last Posted Date: 2022-05-03

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 200

Registration Number: NCT04857073

Locations: 🇺🇸
Mount Sinai Perinatal Associates, New York, New York, United States

RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC

Phase 2

Withdrawn

Conditions: Human Papillomavirus (HPV)
Head and Neck Squamous Cell Carcinoma (HNSCC)

Interventions: Radiation: RT 50 Gy
Radiation: RT 54 GY
Radiation: RT 60 GY
Drug: Cisplatin 200
Other: Induction Therapy
Drug: Carboplatin
Drug: Cisplatin 240

First Posted Date: 2021-04-19

Last Posted Date: 2022-07-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Registration Number: NCT04849377

Locations: 🇺🇸
Mount Sinai Hospital, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy